WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Early Phase 1

Completed

Conditions: Myelodysplastic Syndromes
Leukemia, Myeloid, Acute
Leukemia, Myelogenous, Chronic
Multiple Myeloma

Interventions: Radiation: Dynamic contrast-enhanced computed tomography
Drug: Ioversol

First Posted Date: 2014-04-17

Last Posted Date: 2015-06-11

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 21

Registration Number: NCT02117115

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Enhanced Medical Rehabilitation in Older Adults

Not Applicable

Completed

Conditions: Disabled
Disabling Medical Events
Depression

Interventions: Behavioral: Standard of Care Rehabilitation
Behavioral: Enhanced Medical Rehabilitation

First Posted Date: 2014-04-15

Last Posted Date: 2020-07-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 229

Registration Number: NCT02114879

Locations: 🇺🇸
Barnes-Jewish Extended Care, Saint Louis, Missouri, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Alexian Brothers Sherbrooke Village, Saint Louis, Missouri, United States

A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation

Phase 2

Terminated

Conditions: Multiple Myeloma

Interventions: Drug: Granix
Drug: High dose melphalan (HDR)
Procedure: Autologous Stem Cell Transplant (ASCT)

First Posted Date: 2014-04-11

Last Posted Date: 2019-11-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 90

Registration Number: NCT02112045

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery

Phase 1

Terminated

Conditions: Rectal Neoplasms

Interventions: Radiation: fludeoxyglucose F 18
Device: positron emission tomography
Device: magnetic resonance imaging
Other: laboratory biomarker analysis

First Posted Date: 2014-04-11

Last Posted Date: 2016-12-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 2

Registration Number: NCT02112162

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

Monitoring Brain Perfusion and Cerebral Oximetry in Carotid Endarterectomy Surgeries

Terminated

Conditions: Carotid Endarterectomy

First Posted Date: 2014-04-02

Last Posted Date: 2015-01-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 13

Registration Number: NCT02102386

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

PD 0332991 and Cetuximab in Patients With Incurable SCCHN

Phase 1

Completed

Conditions: Carcinoma, Squamous Cell of Head and Neck

Interventions: Biological: Cetuximab
Drug: PD 0332991

First Posted Date: 2014-04-01

Last Posted Date: 2023-12-21

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 96

Registration Number: NCT02101034

Locations: 🇺🇸
University of Kansas, Westwood, Kansas, United States
🇺🇸
University of Michigan Health System, Ann Arbor, Michigan, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

and more 2 locations

Medication Enhanced Rapid Therapy

Phase 1

Terminated

Conditions: Anxiety Disorders

Interventions: Drug: d-cycloserine and mifepristone

First Posted Date: 2014-03-31

Last Posted Date: 2023-04-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 15

Registration Number: NCT02099825

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Multiple Myeloma
Lymphoma, Non-Hodgkin

Interventions: Drug: XM02 Filgrastim
Drug: Filgrastim
Procedure: Apheresis
Drug: Plerixafor
Procedure: Stem Cell Transplant

First Posted Date: 2014-03-27

Last Posted Date: 2017-07-18

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 100

Registration Number: NCT02098109

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Effect of Skipping Breakfast on Metabolic Function

Not Applicable

Completed

Conditions: Skipping Breakfast
Circadian Rhythms

Interventions: Other: 3 standard meals/day
Other: 2 meals/day (omit breakfast)

First Posted Date: 2014-03-21

Last Posted Date: 2021-03-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT02093572

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Tamoxifen to Treat Barrett's Metaplasia

Early Phase 1

Terminated

Conditions: Barrett Metaplasia

Interventions: Drug: Tamoxifen
Procedure: Endoscopy

First Posted Date: 2014-03-17

Last Posted Date: 2017-03-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 7

Registration Number: NCT02089386

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy